The latest announcement is out from Eyenovia (EYEN).
Eyenovia, Inc. has announced a registered direct offering to certain institutional and accredited investors, selling over 7.5 million shares and warrants with a combined price of $0.66 per share and warrant. The warrants are exercisable at $0.69 per share until January 2030, subject to ownership limits. The company anticipates proceeds of approximately $5 million, aiming to fund product commercialization, clinical studies, and general corporate activities, with potential repayment of existing debts. The offering is contingent on customary closing conditions and is facilitated by Chardan Capital Markets, LLC and Brookline Capital Markets as placement agents.
See more insights into EYEN stock on TipRanks’ Stock Analysis page.
